Get startedLog in
    Picture of Dare Bioscience logo

    DARE — Dare Bioscience News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Daré Bioscience Announces Positive Topline Data From The Mid-Stage Study Of Sildenafil Cream

    Picture of Dare Bioscience logoDare Bioscience
    05/06/2023 14:42
    June 5 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES POSITIVE TOPLINE DATA FROM THE
EXPLORATORY PHASE 2B RESPOND STUDY OF SILDENAFIL CREAM, 3.6% IN
WOMEN WITH FEMALE SEXUAL AROUSAL DISORDER
    * DARE BIOSCIENCE INC - SILDENAFIL CREAM-TREATED PATIENTS
ALSO
SHOWED IMPROVEMENTS IN SECONDARY ENDPOINT

Source text for Eikon:  ID:nGNX9RtcYS 
Further company coverage:  DARE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Dare Bioscience

    See all news